Skip to main content
$85.05 -$0.36 (-0.4%)

04:30 PM EDT on 09/22/20

Immunomedics, Inc. (NASDAQ:IMMU)

CAPS Rating: 2 out of 5

A biopharmaceutical company focused on the development of monoclonal, antibody-based products for the targeted treatment of cancer, autoimmune and other serious diseases.

Current Price $85.05 Mkt Cap $19.7B
Open $85.43 P/E Ratio 0.00
Prev. Close $85.05 Div. (Yield) $0.00 (0.0%)
Daily Range $85.03 - $85.58 Volume 1,289,693
52-Wk Range $8.80 - $86.91 Avg. Daily Vol. 4,681,610

Caps

How do you think NASDAQ:IMMU will perform against the market?

Add Stock to CAPS Watchlist

All Players

222 Outperform
23 Underperform
 

All-Star Players

48 Outperform
3 Underperform
 

Wall Street

0 Outperform
0 Underperform
 

Top NASDAQ:IMMU Bull/Bear Pitches

The best Bull and Bear pitches based on recency and number of recommendations.

NeroSagetrade (74.86)
Submitted October 13, 2007

This is my one...my ONE feel good story in my CAPS portfolio. I've followed Immunomedics for roughly six years and I've liked the direction management has taken the company in each successive year. They have never tried to mislead investors or the… More

zzlangerhans (98.70)
Submitted November 24, 2016

Surprisingly, my recent long bet on Immunomedics turned out to be a winner. Perhaps I have Trump to thank for that since I bought in shortly before the election surprise. Or perhaps I just got lucky: I've made a dozen bottom feeding picks in the last… More

NASDAQ:IMMU VS S&P 500 (SPY)

Fools bullish on NASDAQ:IMMU are also bullish on:

Fools bearish on NASDAQ:IMMU are also bearish on:

Recent Community Commentary

Read the most recent pitches from players about IMMU.

Recs

0
Member Avatar rcortright77 (< 20) Submitted: 12/13/2019 7:30:34 PM : Outperform Start Price: $20.70 NASDAQ:IMMU Score: +307.40

Waiting FDA approval of 132 product. Once approval is received stock will be in the upper 20's or more.

Recs

0
Member Avatar Recycle4u2 (86.18) Submitted: 6/25/2018 7:32:26 PM : Outperform Start Price: $24.01 NASDAQ:IMMU Score: +232.63

Breast cancer drug very promising

Recs

3
Member Avatar zzlangerhans (98.70) Submitted: 11/24/2016 5:24:20 PM : Underperform Start Price: $3.53 NASDAQ:IMMU Score: -2,259.96

Surprisingly, my recent long bet on Immunomedics turned out to be a winner. Perhaps I have Trump to thank for that since I bought in shortly before the election surprise. Or perhaps I just got lucky: I've made a dozen bottom feeding picks in the last couple of months and not of all them can plunge straight down, I suppose. My bull thesis on Immunomedics was that the stock would rocket upward once the company initiated the phase III trial of sacituzumab for triple negative breast cancer and simultaneously filed for accelerated approval. I hoped this would happen around the end of 2016. Instead, Immunomedics recently announced that they wouldn't be initiating the trial until mid 2017, which I anticipate eventually will be narrowed down to Q3 2017 and then more than likely postponed to Q4 2017. Even if they remain on the current schedule, there's a strong likelihood of another below market dilutive financing with warrants before any positive catalyst. The last financing crushed the stock well below the offering price. Another bearish factor is that the share price is approaching the warrant exercise price of 3.75, which could lead to further dilution. I wouldn't short Immunomedics yet, but I was glad to liquidate my long position for a healthy profit and I'll be watching any rise over the warrant exercise price with great interest.

Leaderboard

Find the members with the highest scoring picks in IMMU.

Score Leader

GyroDynasty

GyroDynasty (98.46) Score: +5,255.16

The Score Leader is the player with the highest score across all their picks in IMMU.

Top
Pick
Member Name Member
Rating
Start
Date
Call Time
Frame
Start
Price
Stock
Gain
Index
Gain
Score Commentary
GyroDynasty 98.46 9/29/2015 Outperform 5Y $1.57 +5,317.20% +75.44% +5,241.76 0 Comment
2st2 82.15 1/8/2009 Outperform NS $1.75 +4,760.00% +272.96% +4,487.04 0 Comment
2st4 80.76 1/8/2009 Outperform NS $1.75 +4,760.00% +273.52% +4,486.48 0 Comment
hmcnamee 50.43 5/12/2009 Outperform 1Y $1.81 +4,598.90% +264.24% +4,334.66 1 Comment
skt1986 73.66 11/13/2008 Outperform 1Y $1.89 +4,400.00% +295.48% +4,104.52 0 Comment
khrishnaK 67.55 11/10/2008 Outperform 1Y $1.94 +4,284.02% +256.10% +4,027.93 0 Comment
mikolabruce 76.69 10/10/2006 Outperform 3M $2.00 +4,152.50% +159.48% +3,993.02 0 Comment
pavlos1971 63.34 8/3/2015 Outperform 5Y $2.05 +4,048.78% +56.94% +3,991.84 0 Comment
bibbes 45.06 8/3/2015 Outperform 5Y $2.05 +4,048.78% +56.94% +3,991.84 0 Comment
wmtworker 80.54 8/3/2015 Outperform 5Y $2.05 +4,048.78% +56.94% +3,991.84 0 Comment

Wall Street

See what the Wall Street professionals think, according to their public statements and filings.

There are no Wall Street tracker picks for IMMU.